Cargando…

Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model

Detalles Bibliográficos
Autores principales: Srivastava, Raghvendra M, Clump, David A, Ferris, Robert L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649308/
http://dx.doi.org/10.1186/2051-1426-3-S2-P314
_version_ 1782401329806704640
author Srivastava, Raghvendra M
Clump, David A
Ferris, Robert L
author_facet Srivastava, Raghvendra M
Clump, David A
Ferris, Robert L
author_sort Srivastava, Raghvendra M
collection PubMed
description
format Online
Article
Text
id pubmed-4649308
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46493082015-11-24 Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model Srivastava, Raghvendra M Clump, David A Ferris, Robert L J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649308/ http://dx.doi.org/10.1186/2051-1426-3-S2-P314 Text en Copyright © 2015 Srivastava et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Srivastava, Raghvendra M
Clump, David A
Ferris, Robert L
Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
title Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
title_full Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
title_fullStr Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
title_full_unstemmed Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
title_short Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model
title_sort anti-pd-1 mab pre-radiotherapy (rt) loading dose and fractionated rt induce better tumor-specific immunity and tumor shrinkage than sequential administration in an hpv+ head and neck cancer model
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649308/
http://dx.doi.org/10.1186/2051-1426-3-S2-P314
work_keys_str_mv AT srivastavaraghvendram antipd1mabpreradiotherapyrtloadingdoseandfractionatedrtinducebettertumorspecificimmunityandtumorshrinkagethansequentialadministrationinanhpvheadandneckcancermodel
AT clumpdavida antipd1mabpreradiotherapyrtloadingdoseandfractionatedrtinducebettertumorspecificimmunityandtumorshrinkagethansequentialadministrationinanhpvheadandneckcancermodel
AT ferrisrobertl antipd1mabpreradiotherapyrtloadingdoseandfractionatedrtinducebettertumorspecificimmunityandtumorshrinkagethansequentialadministrationinanhpvheadandneckcancermodel